Allergy
Conditions
Keywords
Wasp venom allergy,, specific immunotherapy
Brief summary
The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy
Interventions
BIOLOGICALwasp venom
Sponsors
Allergopharma GmbH & Co. KG
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* History of wasp venom allergy, * Positive RAST to wasp venom, * Positive skin prick test to wasp venom
Exclusion criteria
* Serious chronic diseases
Countries
Germany
Outcome results
None listed